The impact of hypoxia on bacterial infection

FEBS Journal

Volumn 282, Issue 12, 2015, Pages 2260-2266

  Schaffer, Kirsten ^a   Taylor, Cormac T ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

hydroxylase; immunity; inflammation

Indexed keywords

CATHELICIDIN; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; TRANSCRIPTION FACTOR; HYPOXIA INDUCIBLE FACTOR 1;

ADAPTIVE IMMUNITY; ANIMAL MODEL; ASPERGILLUS FUMIGATUS; BACTERIAL INFECTION; BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DROSOPHILA MELANOGASTER; HUMAN; HYPOXEMIA; INFLAMMATION; INNATE IMMUNITY; INTESTINE INFECTION; LYMPHOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; VIBRIO CHOLERAE; ANIMAL; BIOLOGICAL MODEL; CELL HYPOXIA; GENETICS; HYDROXYLATION; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PROTEIN PROCESSING; PROTEIN STABILITY;

BACTERIA (MICROORGANISMS);

ADAPTIVE IMMUNITY; ANIMALS; BACTERIAL INFECTIONS; CELL HYPOXIA; DISEASE PROGRESSION; HUMANS; HYDROXYLATION; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY;

EID: 84935878792     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13270     Document Type: Review

References (47)

1. Eltzschig HK, &, Carmeliet P, (2011) Hypoxia and inflammation. N Engl J Med 364, 656-665.
2. Palazon A, Goldrath AW, Nizet V, &, Johnson RS, (2014) HIF transcription factors, inflammation, and immunity. Immunity 41, 518-528.
3. Bhandari T, &, Nizet V, (2014) Hypoxia-inducible factor (HIF) as a pharmacological target for prevention and treatment of infectious diseases. Infect Dis Ther. [Epub ahead of print].
4. Colgan SP, &, Taylor CT, (2010) Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7, 281-287.
5. Campbell EL, Bruyninckx WJ, Kelly CJ, Glover LE, McNamee EN, Bowers BE, Bayless AJ, Scully M, Saeedi BJ, Golden-Mason L, et al,. (2014) Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40, 66-77.
6. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, et al,. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109, 317-325.
7. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein E, Manjunatha U, Gonzales J, et al,. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76, 2333-2340.
8. Grahl N, Puttikamonkul S, Macdonald JM, Gamcsik MP, Ngo LY, Hohl TM, &, Cramer RA, (2011) In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis. PLoS Pathog 7, e1002145.
9. Taylor CT, &, McElwain JC, (2010) Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology (Bethesda) 25, 272-279.
10. Wang GL, &, Semenza GL, (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90, 4304-4308.
11. Semenza GL, (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
12. Kaelin WG Jr, &, Ratcliffe PJ, (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30, 393-402.
13. Schofield CJ, &, Ratcliffe PJ, (2005) Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commun 338, 617-626.
14. Schaible B, McClean S, Selfridge A, Broquet A, Asehnoune K, Taylor CT, &, Schaffer K, (2013) Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS One 8, e56491.
15. Cummins EP, &, Taylor CT, (2005) Hypoxia-responsive transcription factors. Pflugers Arch 450, 363-371.
16. Taylor CT, &, Cummins EP, (2009) The role of NF-kappaB in hypoxia-induced gene expression. Ann N Y Acad Sci 1177, 178-184.
17. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, et al,. (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 103, 18154-18159.
18. Sever JL, &, Youmans GP, (1957) The relation of oxygen tension to virulence of tubercle bacilli and to acquired resistance in tuberculosis. J Infect Dis 101, 193-202.
19. Jiang H, Guo R, &, Powell-Coffman JA, (2001) The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia. Proc Natl Acad Sci USA 98, 7916-7921.
20. Gallagher LA, &, Manoil C, (2001) Pseudomonas aeruginosa PAO1 kills Caenorhabditis elegans by cyanide poisoning. J Bacteriol 183, 6207-6214.
21. Darby C, Cosma CL, Thomas JH, &, Manoil C, (1999) Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 96, 15202-15207.
22. Bellier A, Chen C-S, Kao C-Y, Cinar HN, &, Aroian RV, (2009) Hypoxia and the hypoxic response pathway protect against pore-forming toxins in C. elegans. PLoS Pathog 5, e1000689.
23. Shao Z, Zhang Y, Ye Q, Saldanha JN, &, Powell-Coffman JA, (2010) C. elegans SWAN-1 Binds to EGL-9 and regulates HIF-1-mediated resistance to the bacterial pathogen Pseudomonas aeruginosa PAO1. PLoS Pathog 6, e1001075.
24. Gan YH, Chua KL, Chua HH, Liu B, Hii CS, Chong HL, &, Tan P, (2002) Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol Microbiol 44, 1185-1197.
25. Luhachack LG, Visvikis O, Wollenberg AC, Lacy-Hulbert A, Stuart LM, &, Irazoqui JE, (2012) EGL-9 controls C. elegans host defense specificity through prolyl hydroxylation-dependent and -independent HIF-1 pathways. PLoS Pathog 8, e1002798.
26. Banderra B, Biddlestone J, Mudie S, Muller HAJ, &, Rocha S, (2015) HIF-1a restricts NF-kB-dependent gene expression to control innate immunity signals. Dis Model Mech 8, 169-181.
27. Berger EA, McClellan SA, Vistisen KS, &, Hazlett LD, (2013) HIF1alpha is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa Keratitis. PLoS Pathog 9, e1003457.
28. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, &, Johnson RS, (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115, 1806-1815.
29. Peyssonnaux C, Boutin AT, Zinkernagel AS, Datta V, Nizet V, &, Johnson RS, (2008) Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J Invest Dermatol 128, 1964-1968.
30. Zinkernagel AS, Peyssonnaux C, Johnson RS, &, Nizet V, (2008) Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J Infect Dis 197, 214-217.
31. Okumura CY, Hollands A, Tran DN, Olson J, Dahesh S, von Köckritz-Blickwede M, Thienphrapa W, Corle C, Jeung SN, Kotsakis A, et al,. (2012) A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J Mol Med 90, 1079-1089.
32. Hartmann H, Eltzschig HK, Wurz H, Hantke K, Rakin A, Yazdi AS, Matteoli G, Bohn E, Autenrieth IB, Karhausen J, et al,. (2008) Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 134, 756-767.
33. Hirota SA, Fines K, Ng J, Traboulsi D, Lee J, Ihara E, Li Y, Willmore WG, Chung D, Scully MM, et al,. (2010) Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology 139, 259-269.
34. Elks PM, Brizee S, van der Vaart M, Walmsley SR, van Eeden FJ, Renshaw SA, &, Meijer AH, (2013) Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism. PLoS Pathog 9, e1003789. doi: 10.1371/journal.ppat.1003789.
35. Oehlers SH, Cronan MR, Scott NR, Thomas MI, Okuda KS, Walton EM, Beerman RW, Crosier PS, &, Tobin DM, (2015) Interception of host angiogenic signalling limits mycobacterial growth. Nature 517, 612-615.
36. Hams E, Saunders SP, Cummins EP, O'Connor A, Tambuwala MT, Gallagher WM, Byrne A, Campos-Torres A, Moynagh PM, Jobin C, et al,. (2011) The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells. Shock 36, 295-302.
37. Georgiev P, Belikoff BG, Hatfield S, Ohta A, Sitkovsky MV, &, Lukashev D, (2013) Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model. Eur J Immunol 43, 655-666.
38. Mahabeleshwar GH, Qureshi MA, Takami Y, Sharma N, Lingrel JB, &, Jain MK, (2012) A myeloid hypoxia-inducible factor 1α-Krüppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis. J Biol Chem 287, 1448-1457.
39. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, Bernhardt W, von Eiff C, Becker K, Schäfer A, et al,. (2010) Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 5, e11576.
40. Nizet V, &, Johnson RS, (2009) Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9, 609-617.
41. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al,. (2013) Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238-242.
42. Kempf VA, Lebiedziejewski M, Alitalo K, Wälzlein JH, Ehehalt U, Fiebig J, Huber S, Schütt B, Sander CA, Müller S, et al,. (2005) Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 111, 1054-1062.
43. Marteyn B, West NP, Browning DF, Cole JA, Shaw JG, Palm F, Mounier J, Prévost MC, Sansonetti P, &, Tang CM,. (2010) Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465, 355-358.
44. Scotti JS, Leung IK, Ge W, Bentley MA, Paps J, Kramer HB, Lee J, Aik W, Choi H, Paulsen SM, et al,. (2014) Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation. Proc Natl Acad Sci USA 111, 13331-13336.
45. Schaible B, Taylor CT, &, Schaffer K, (2012) Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps. Antimicrob Agents Chemother 56, 2114-2118.
46. Gomez JE, &, McKinney JD, (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84, 29-44.
47. Rustad TR, Sherrid AM, Minch KJ, &, Sherman DR, (2009) Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol 11, 1151-1159.